These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 3365068

  • 1. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
    Nishikibe M, Nagura J, Kamei K, Fukuroda T.
    Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
    [Abstract] [Full Text] [Related]

  • 2. Effect of the newly synthetized calcium antagonist isopropyl methyl 2-carbamoyloxymethyl-6-methyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5- dicarboxylate on cerebral venous outflow in dogs.
    Nishikibe M, Kamei K, Nagura J, Suzuki K.
    Arzneimittelforschung; 1989 Jun; 39(6):678-81. PubMed ID: 2775334
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
    Mori T, Nakayama N, Ohura M, Ikezono K, Kinoshita S, Kamata M, Hosokawa T, Yamashita S, Yabuuchi Y.
    Arch Int Pharmacodyn Ther; 1993 Jun; 321():41-56. PubMed ID: 8323415
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H, Matsui K, Ochi S, Nakazawa M, Nakagawa Y, Imai S.
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of a new dihydropyridine calcium antagonist.
    Kimura Y, Fukui H, Tanaka M, Okamoto M, Miura A, Kimura K, Enomoto H.
    Arzneimittelforschung; 1986 Sep; 36(9):1336-44. PubMed ID: 3790183
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine.
    Nishikibe M, Fukuroda T, Nakajima A.
    Arch Int Pharmacodyn Ther; 1989 Sep; 297():98-111. PubMed ID: 2730244
    [Abstract] [Full Text] [Related]

  • 14. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
    Takata Y, Kato H.
    Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the cardiovascular effects of three dihydropyridine compounds.
    Nagura J, Suzuki K, Shiratori K, Fukuroda T, Nishikibe M, Murayama B, Takeya K.
    Arch Int Pharmacodyn Ther; 1989 Oct; 302():174-85. PubMed ID: 2636815
    [Abstract] [Full Text] [Related]

  • 16. Regional vasodilating and cardiac effects of nicardipine in anaesthetized open chest dog.
    Bongrani S, Razzetti R, Schiantarelli P.
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):226-36. PubMed ID: 4004418
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T, Kase N, Kita H, Uematsu T.
    Arzneimittelforschung; 1986 Feb; 36(1):29-34. PubMed ID: 3754142
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fantofarone (SR 33557): cardiovascular actions in anesthetized dogs.
    Barthélémy G, Chatelain P, Manning A.
    Arch Int Pharmacodyn Ther; 1994 Feb; 327(2):204-19. PubMed ID: 7979829
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.